Combination Antiretroviral Therapy (cART) Component Ritonavir Significantly Alters Docetaxel Exposure
Cancer Chemotherapy and Pharmacology - Germany
doi 10.1007/s00280-014-2399-7
Full Text
Open PDFAbstract
Available in full text
Date
February 2, 2014
Authors
Publisher
Springer Science and Business Media LLC